Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Treatment Algorithms for Difficult-to-treat Asthma
NCT04179461Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Mar 2018
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d, antihistamine (TDDS/ODF), azithromycin, fluticasone propionate nasal spray in asthma, sponsored by Cincinnati Children's Hospital Medical Center. Started Mar 2018; status: completed.
02
Drugs
vitamin dantihistamine (TDDS/ODF)azithromycinfluticasone propionate nasal spray
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04179461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04179461.